Over the past year, shares of Globus Medical GMED and Medtronic MDT have gained 46.1% and 7.6%, respectively, significantly ...

Medtronic (NYSE:MDT) is one of the best long term stocks to buy according to hedge funds. On June 8, Medtronic received FDA ...

On June 25, Allan Small, Senior Investment Advisor at Allan Small Financial Group, appeared on BNN Bloomberg to discuss ...

Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...

Masimo study finds less than 1% bias and no skin tone discrepancies in neonatal pulse oximetry accuracy. NeoPODS data shows reliable SpO2 readings with minimal hypoxemia cases across diverse newborn ...

Following the March 2026 update for Google Pixel Watch devices, a number of users are reporting that their SpO2 (blood oxygen) and skin temperature readings have vanished from the Fitbit app. The ...

Medtronic and GE HealthCare inked a multiyear deal to expand their more than three-decade-long partnership that aims to boost clinical and technology innovation. Medtronic and GE HealthCare inked a ...

Medtronic and Mindray North America expanded their partnership on patient monitoring technology beyond hospitals into ASCs in the United States, according to a Jan. 22 news release. The companies said ...

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...